Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Basic leucine zipper and W2 domain-containing protein 1 (BZW1) mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the BZW1 transcript that governs gene expression through post-transcriptional mechanisms. BZW1 itself is a protein involved in the regulation of translation initiation and is frequently overexpressed in various malignancies, where it promotes cell proliferation and epithelial-mesenchymal transition (EMT). The 3'-UTR contains multiple binding sites for microRNAs, such as miR-129-5p and miR-145, which normally act as tumor suppressors by limiting BZW1 production. In many cancers, the downregulation of these microRNAs leads to the stabilization and increased translation of BZW1 mRNA, driving tumor progression. Consequently, the BZW1 mRNA 3'-UTR is viewed as a significant therapeutic target for RNA-based interventions, including miRNA mimics and antisense oligonucleotides, aimed at restoring normal regulatory control and inhibiting oncogenic signaling. Research indicates that targeting this region can effectively reduce the metastatic potential and growth of cancer cells in preclinical models.
The 3'-UTR of BZW1 mRNA serves as a binding site for regulatory microRNAs (miRNAs) which induce translational repression or mRNA degradation. Therapeutic strategies involve using miRNA mimics to downregulate BZW1 expression or antisense oligonucleotides (ASOs) to interfere with regulatory protein binding, thereby inhibiting the oncogenic functions of BZW1 in tumor cells.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Basic leucine zipper and W2 domain-containing protein 1 mRNA 3'-untranslated region (BZW1 mRNA 3'-UTR).